# Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024

## TL;DR

This paper summarizes key insights from a congress on cancer immunotherapy, highlighting advances in cellular therapies and challenges in their implementation.

## Contribution

The paper provides a comprehensive review of recent immunotherapy developments and challenges discussed at the ADSCC congress.

## Key findings

- Experts emphasized biomarker identification to improve patient selection and treatment efficacy.
- Emerging strategies like next-generation CAR-T and gene-editing technologies were highlighted for enhancing therapy durability.
- The congress fostered international collaborations and knowledge exchange among over 2,300 participants.

## Abstract

The rising global cancer burden underscores the urgent need for innovative and effective therapies. Molecular and cellular immunology advances have revolutionized cancer immunotherapy, transforming laboratory discoveries into clinical breakthroughs. The Second Bone Marrow Transplant and Cellular Therapy Congress, held in Abu Dhabi, United Arab Emirates (UAE), on October 26th - 27th, 2024, and sponsored by the Abu Dhabi Stem Cells Center (ADSCC), convened global experts to discuss cutting-edge developments in adoptive cell transfer (ACT); chimeric antigen receptor T-cell (CAR-T) therapy, tumor-infiltrating lymphocyte (TIL) engineering and T-cell receptor (TCR) innovations. Discussions covered key challenges such as tumor microenvironment (TME) resistance, antigen escape, manufacturing complexity, cost-effectiveness, and accessibility. Experts emphasized the crucial role of biomarker identification in optimizing patient selection and improving treatment efficacy. Additionally, emerging strategies were highlighted to enhance the durability and specificity of cellular therapies, including next-generation CAR-T designs, combination approaches, and novel gene-editing technologies. With over 2,300 participants from academia, research, and healthcare, the event fostered international collaborations and knowledge exchange. The ADSCC continues to play a pivotal role in integrating advanced cellular therapies into healthcare systems, contributing to the expansion of precision oncology in the UAE and beyond. This review analyzes the latest advances in immunotherapy, highlighting their clinical impact, challenges, and future directions in the evolving landscape of cancer treatment, as debated during the congress.